Inhibition of ICAM1 diminishes stemness and enhances antitumor immunity in glioblastoma via β-catenin/PD-L1 signaling. - Guo M; Yuan Z; Jin X; Li X; Deng Y; Zhou S; Niu R; Bae J; Park JB; Shi B; Yin J (Nature communications, 2025)